Retrovir 10 mg/ml IV concentrate for solution for infusion
Concentrate for solution for infusion
Compare
|
PA22575/001/003
Authorised: 29/07/2011
ViiV Healthcare BV
|
SPC
PIL
|
Retrovir 100 mg capsules, hard
Capsule, hard
Compare
|
PA22575/001/001
Authorised: 29/07/2011
ViiV Healthcare BV
|
SPC
PIL
|
Retrovir 100 mg/10 ml oral solution
Oral solution
Compare
|
PA22575/001/002
Authorised: 30/09/2011
ViiV Healthcare BV
|
SPC
PIL
|
Retsevmo
Capsule, hard
Compare
|
EU/1/20/1527/001
Authorised: 11/02/2021
Eli Lilly Nederland B.V.
|
SPC
PIL
IPAR
|
Retsevmo
Capsule, hard
Compare
|
EU/1/20/1527/002-003
Authorised: 11/02/2021
Eli Lilly Nederland B.V.
|
SPC
PIL
IPAR
|
Revatio
Film-coated tablet
Generics List:
Sildenafil 20mg Film-coated Tablets
Compare
|
EU/1/05/318/001
Upjohn EESV
|
SPC
PIL
IPAR
|
Revatio
Solution for injection
Compare
|
EU/1/05/318/002
Authorised: 10/12/2009
Upjohn EESV
|
SPC
PIL
IPAR
|
Revatio
Powder for oral suspension
Compare
|
EU/1/05/318/003
Authorised: 21/03/2012
Upjohn EESV
|
SPC
PIL
IPAR
|
REVAXIS Suspension for injection in pre-filled syringe Diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
Suspension for injection in pre-filled syringe
Compare
|
PA2131/007/001
Authorised: 18/02/2000
Sanofi Pasteur
|
SPC
PIL
|
Revestive
Powder and solvent for solution for injection
Compare
|
EU/1/12/787/001
Takeda Pharmaceuticals International AG Ireland Branch
|
SPC
PIL
IPAR
|
Revestive
Powder and solvent for solution for injection
Compare
|
EU/1/12/787/003
Authorised: 23/06/2017
Takeda Pharmaceuticals International AG Ireland Branch
|
SPC
PIL
IPAR
|
Revinty Ellipta
Inhalation powder, pre-dispensed
Compare
|
EU/1/14/929/001-003
Authorised: 17/06/2014
GlaxoSmithKline (Ireland) Limited
|
SPC
PIL
IPAR
|
Revinty Ellipta
Inhalation powder, pre-dispensed
Compare
|
EU/1/14/929/004-006
Authorised: 17/06/2014
GlaxoSmithKline (Ireland) Limited
|
SPC
PIL
IPAR
|
Revlimid
Capsule, hard
Compare
|
EU/1/07/391/001
Bristol-Myers Squibb Pharma EEIG
|
SPC
PIL
IPAR
EdM
|
Revlimid
Capsule, hard
Compare
|
EU/1/07/391/002
Authorised: 14/06/2007
Bristol-Myers Squibb Pharma EEIG
|
SPC
PIL
IPAR
EdM
|
Revlimid
Capsule, hard
Compare
|
EU/1/07/391/003
Authorised: 14/06/2007
Bristol-Myers Squibb Pharma EEIG
|
SPC
PIL
IPAR
EdM
|
Revlimid
Capsule, hard
Compare
|
EU/1/07/391/004
Authorised: 14/06/2007
Bristol-Myers Squibb Pharma EEIG
|
SPC
PIL
IPAR
EdM
|
Revlimid
Capsule, hard
Compare
|
EU/1/07/391/005
Authorised: 10/09/2012
Bristol-Myers Squibb Pharma EEIG
|
SPC
PIL
IPAR
EdM
|
Revlimid
Capsule, hard
Compare
|
EU/1/07/391/006
Authorised: 10/09/2012
Bristol-Myers Squibb Pharma EEIG
|
SPC
PIL
IPAR
EdM
|
Revlimid
Capsule, hard
Compare
|
EU/1/07/391/009
Authorised: 19/02/2015
Bristol-Myers Squibb Pharma EEIG
|
SPC
PIL
IPAR
EdM
|